Day: March 24, 2021

FORT LEE, NJ, March 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Clikia Corp. (OTC: CLKA) (“Clikia” or the “Company”), an emerging leader in the global high-end custom luxury goods marketplace, through its wholly owned subsidiary, Maison Luxe, is pleased to announce the appointment of former Cartier Vice-President of Marketing and former Chopard President of North America Thierry Chaunu to the Company’s Board of Directors. “Thierry’s career is a highlight reel of leading firms and prominent roles in the diamond and jewelry space, and we are incredibly fortunate to have him involved at this stage,” commented Anil Idnani, CEO of Clikia and Founder of Maison Luxe. Chaunu began his jewelry career as Senior Product Manager in Paris in the 1980’s with the world-renowned French luxury goods conglomerate Cartier, before being promoted...

LAS VEGAS, March 24, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Asia Broadband Inc. (OTC : AABB) is pleased to announce that the Company has finalized the financial results for the year ending December 31, 2020, and has achieved an all-time high annual gross profit of $16.8 million. The Company recently received its final 2020 year-end price adjusted gold and silver sales revenues and will be publishing the annual report in the coming week. The accomplishment of this financial milestone attests the Company’s successful mining operations established in 2020. AABB’s strategic growth focus has allowed the Company to capitalize on a unique ability to vertically integrate mineral resource production in Mexico with a high resource demand and abundant investment capital in Asia. In 2021, AABB shifted its focus to leverage its resources...

OMER, Israel, March 24, 2021 (GLOBE NEWSWIRE) — ScoutCam (OTCQB:SCTC), a leading developer and manufacturer of customized micro visual solutions and supplementary technologies, today announced a private placement of $20,000,000 from first tier Israeli institutional investors. The closing of the private placement is expected to occur by March 31, 2021. In connection with the private placement, the board of directors of the Company resolved to take steps to promote the uplisting of the Company to the Nasdaq Stock Market. Net proceeds of the offering will be used by the Company to further advance its innovative products and technology in the medical device sector and into the fields of maintenance and predictive maintenance, a critical pillar of Industry 4.0. As part of the agreements, ScoutCam will issue the investors 22,222,223 shares...

Landsbréf – BÚS I ársreikningur 2020 AttachmentLandsbréf – BÚS I ársreikningur 2020

Landsbréf – BÚS I – ársreikningur 2020 ViðhengiLandsbréf – BÚS I ársreikningur 2020

TORONTO, March 24, 2021 (GLOBE NEWSWIRE) — Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce an update on the Company’s U.S. Food & Drug Administration (“FDA”) Phase 3 clinical trial (the “Study”) to evaluate the safety and efficacy of Bucillamine in patients with mild to moderate COVID-19. The Company currently has partnered with 14 clinical sites in six states including California, Florida, Illinois, Nevada, North Carolina and Texas and is now expanding to up to 50 clinical sites within the current states and in COVID-19 hot spot states such as Massachusetts, Michigan, New Jersey, New York, Pennsylvania, and South Carolina. The Company is on track...

TORONTO, March 24, 2021 (GLOBE NEWSWIRE) — Class 1 Nickel and Technologies Ltd. (CSE: NICO/OTCQB: NICLF) (“Class 1 Nickel” or the “Company”) is pleased to announce the appointment of Mr. Mathew Fitch as a director of the Company. Mr Mathew Fitch’s appointment further strengthens the Company’s Board of Directors and management team. Mathew Fitch is a co-founder of Fusion Capital, which incorporates Bustech Group, Brabham Automotive, HeliostatSA and EVANT. Bustech Group is Australia’s largest privately owned manufacturer of diesel, electric and hydrogen Buses. His ownership interest is spread across the Hospitality, Advanced Manufacturing, Automotive, Property and Development Sectors. His background as a Financial Accountant for both Bentleys & KPMG provided a strong platform to undertake his previous...

TORONTO, March 24, 2021 (GLOBE NEWSWIRE) — Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF), announced today it has entered into an exclusive agreement with the University of Cincinnati (UC) to license new patent claims for an AB569 topical wound application designed to prevent, treat and heal burn/blast wound infections. AB569 was invented by Dr. Daniel Hassett at UC to target multi-drug resistant infections that are difficult to treat in the lungs, wounds of soldiers (burns or blast), surgical incisions and diabetic skin ulcers. This new agreement builds on the existing license of AB569 that Arch has with UC. “With this new license, Arch now has a commercial path to develop the topical wound gel version of AB569 for clinical use. We look forward to exploring opportunities where Arch can support...